Gene carrier showing all-or-none response to cancer cell signaling

Riki Toita, Jeong Hun Kang, Tetsuro Tomiyama, Chan Woo Kim, Shujiro Shiosaki, Takuro Niidome, Takeshi Mori, Yoshiki Katayama

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

In this work we designed a novel nano carrier, a linear polyethylenimine (LPEI)-peptide conjugate, for cancer-specific expression of transgenes. The conjugate was easily synthesized by using a click chemistry scheme orthogonal to the reactive side groups of the peptide, which is the substrate of protein kinase Cα (PKCα). Polyplexes of the conjugates with plasmid DNA (pDNA) were intact and stably dispersed even in the presence of cell lysate. Despite this stability, the polyplexes readily dissociated upon phosphorylation of the grafted peptides by PKCα. Because of its endosomal escape ability and adequate susceptibility to PKCα, the polyplexes showed an all-or-none type response to PKCα activity in transgene expression in vitro. The polyplexes achieved cancer tissue-specific transgene expression even for a tumor with a relatively low PKCα activity. Thus the LPEI-peptide conjugate has high potential as a nanocarrier for cancer-targeted gene therapy.

Original languageEnglish
Pages (from-to)15410-15417
Number of pages8
JournalJournal of the American Chemical Society
Volume134
Issue number37
DOIs
Publication statusPublished - Sep 19 2012

Fingerprint

Cell signaling
Protein Kinase C
Genes
Peptides
Proteins
Transgenes
Polyethyleneimine
Neoplasms
Click Chemistry
Gene therapy
Phosphorylation
Neoplasm Genes
Genetic Therapy
Tumors
Plasmids
DNA
Tissue
Substrates

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Chemistry(all)
  • Biochemistry
  • Colloid and Surface Chemistry

Cite this

Toita, R., Kang, J. H., Tomiyama, T., Kim, C. W., Shiosaki, S., Niidome, T., ... Katayama, Y. (2012). Gene carrier showing all-or-none response to cancer cell signaling. Journal of the American Chemical Society, 134(37), 15410-15417. https://doi.org/10.1021/ja305437n

Gene carrier showing all-or-none response to cancer cell signaling. / Toita, Riki; Kang, Jeong Hun; Tomiyama, Tetsuro; Kim, Chan Woo; Shiosaki, Shujiro; Niidome, Takuro; Mori, Takeshi; Katayama, Yoshiki.

In: Journal of the American Chemical Society, Vol. 134, No. 37, 19.09.2012, p. 15410-15417.

Research output: Contribution to journalArticle

Toita, R, Kang, JH, Tomiyama, T, Kim, CW, Shiosaki, S, Niidome, T, Mori, T & Katayama, Y 2012, 'Gene carrier showing all-or-none response to cancer cell signaling', Journal of the American Chemical Society, vol. 134, no. 37, pp. 15410-15417. https://doi.org/10.1021/ja305437n
Toita R, Kang JH, Tomiyama T, Kim CW, Shiosaki S, Niidome T et al. Gene carrier showing all-or-none response to cancer cell signaling. Journal of the American Chemical Society. 2012 Sep 19;134(37):15410-15417. https://doi.org/10.1021/ja305437n
Toita, Riki ; Kang, Jeong Hun ; Tomiyama, Tetsuro ; Kim, Chan Woo ; Shiosaki, Shujiro ; Niidome, Takuro ; Mori, Takeshi ; Katayama, Yoshiki. / Gene carrier showing all-or-none response to cancer cell signaling. In: Journal of the American Chemical Society. 2012 ; Vol. 134, No. 37. pp. 15410-15417.
@article{47aba762751d45c59b541f3d1295d478,
title = "Gene carrier showing all-or-none response to cancer cell signaling",
abstract = "In this work we designed a novel nano carrier, a linear polyethylenimine (LPEI)-peptide conjugate, for cancer-specific expression of transgenes. The conjugate was easily synthesized by using a click chemistry scheme orthogonal to the reactive side groups of the peptide, which is the substrate of protein kinase Cα (PKCα). Polyplexes of the conjugates with plasmid DNA (pDNA) were intact and stably dispersed even in the presence of cell lysate. Despite this stability, the polyplexes readily dissociated upon phosphorylation of the grafted peptides by PKCα. Because of its endosomal escape ability and adequate susceptibility to PKCα, the polyplexes showed an all-or-none type response to PKCα activity in transgene expression in vitro. The polyplexes achieved cancer tissue-specific transgene expression even for a tumor with a relatively low PKCα activity. Thus the LPEI-peptide conjugate has high potential as a nanocarrier for cancer-targeted gene therapy.",
author = "Riki Toita and Kang, {Jeong Hun} and Tetsuro Tomiyama and Kim, {Chan Woo} and Shujiro Shiosaki and Takuro Niidome and Takeshi Mori and Yoshiki Katayama",
year = "2012",
month = "9",
day = "19",
doi = "10.1021/ja305437n",
language = "English",
volume = "134",
pages = "15410--15417",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "37",

}

TY - JOUR

T1 - Gene carrier showing all-or-none response to cancer cell signaling

AU - Toita, Riki

AU - Kang, Jeong Hun

AU - Tomiyama, Tetsuro

AU - Kim, Chan Woo

AU - Shiosaki, Shujiro

AU - Niidome, Takuro

AU - Mori, Takeshi

AU - Katayama, Yoshiki

PY - 2012/9/19

Y1 - 2012/9/19

N2 - In this work we designed a novel nano carrier, a linear polyethylenimine (LPEI)-peptide conjugate, for cancer-specific expression of transgenes. The conjugate was easily synthesized by using a click chemistry scheme orthogonal to the reactive side groups of the peptide, which is the substrate of protein kinase Cα (PKCα). Polyplexes of the conjugates with plasmid DNA (pDNA) were intact and stably dispersed even in the presence of cell lysate. Despite this stability, the polyplexes readily dissociated upon phosphorylation of the grafted peptides by PKCα. Because of its endosomal escape ability and adequate susceptibility to PKCα, the polyplexes showed an all-or-none type response to PKCα activity in transgene expression in vitro. The polyplexes achieved cancer tissue-specific transgene expression even for a tumor with a relatively low PKCα activity. Thus the LPEI-peptide conjugate has high potential as a nanocarrier for cancer-targeted gene therapy.

AB - In this work we designed a novel nano carrier, a linear polyethylenimine (LPEI)-peptide conjugate, for cancer-specific expression of transgenes. The conjugate was easily synthesized by using a click chemistry scheme orthogonal to the reactive side groups of the peptide, which is the substrate of protein kinase Cα (PKCα). Polyplexes of the conjugates with plasmid DNA (pDNA) were intact and stably dispersed even in the presence of cell lysate. Despite this stability, the polyplexes readily dissociated upon phosphorylation of the grafted peptides by PKCα. Because of its endosomal escape ability and adequate susceptibility to PKCα, the polyplexes showed an all-or-none type response to PKCα activity in transgene expression in vitro. The polyplexes achieved cancer tissue-specific transgene expression even for a tumor with a relatively low PKCα activity. Thus the LPEI-peptide conjugate has high potential as a nanocarrier for cancer-targeted gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=84866524406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866524406&partnerID=8YFLogxK

U2 - 10.1021/ja305437n

DO - 10.1021/ja305437n

M3 - Article

C2 - 22920909

AN - SCOPUS:84866524406

VL - 134

SP - 15410

EP - 15417

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 37

ER -